05 December 2023>: Database Analysis
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
Jeeyeon Lee 12ABCDEF , Maria Jose Aguilera Chuchuca 1CDF , Jisang Yu 1BC , Liam Il-Young Chung 1AEF , Ankit Bharat 1ABCDEFG* , Young Kwang Chae 1A*DOI: 10.12659/AOT.941301
Ann Transplant 2023; 28:e941301
Table 3 Clinical characteristics in patients who received double-lung transplantation (DLT) for non-cancerous disease from Organ Procurement Transplantation Network (OPTN) registry.
Variables | Lung cancer post-transplant (n=220) | No malignancy post-transplant (n=29,100) |
---|---|---|
Age at transplantation (n, %) | ||
≤50 years | 58 (26.4) | 11,071 (38.0) |
>50 years | 162 (73.6) | 18,029 (198.1) |
Sex (n, %) | ||
Male | 150 (68.2) | 16,536 (56.8) |
Female | 70 (31.8) | 12,564 (43.2) |
Death (n, %) | ||
No | 15 (6.8) | 14,456 (49.7) |
Yes | 205 (93.2) | 14,644 (50.3) |
Overall survival | ||
Median (range, months) | 51.3 (0.9–352.8) | 36.9 (0.0–376.8) |
3-year (n, %) | 140/220 (63.6) | 15,315/29,100 (52.6) |
5-year (n, %) | 104/220 (47.3) | 10,404/29,100 (35.8) |